Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;10(3):391-9.
doi: 10.1007/s13311-013-0182-9.

α-Synuclein and mitochondria: partners in crime?

Affiliations
Review

α-Synuclein and mitochondria: partners in crime?

Ken Nakamura. Neurotherapeutics. 2013 Jul.

Abstract

Increased α-synuclein levels and mutations in mitochondria-associated proteins both cause familial Parkinson's disease (PD), and synuclein and mitochondria also play central, but poorly understood, roles in the pathogenesis of idiopathic PD. A fraction of synuclein interacts with mitochondria, and synuclein can produce mitochondrial fragmentation and impair mitochondrial complex I activity. However, the consequences of these mitochondrial changes for bioenergetic and other mitochondrial functions remain poorly defined, as does the role of synuclein-mitochondria interactions in the normal and pathologic effects of synuclein. Understanding the functional consequences of synuclein's interactions with mitochondria is likely to provide important insights into disease pathophysiology, and may also reveal therapeutic strategies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Hypothetical schema of synuclein interactions with mitochondria normally and in Parkinson’s disease (PD). Under normal conditions, most synuclein is cytosolic in transiently “closed” conformations. However, a fraction of synuclein binds to mitochondria and is stabilized in a relatively “open” conformation [17]. In PD, synuclein levels are increased and a higher proportion of synuclein may exist in an oligomeric conformation, which also interacts with mitochondria [25, 48]. Increased synuclein monomers and/or oligomers drive increased mitochondrial fission, leading to more fragmented mitochondrial morphology. ER = endoplasmic reticulum
Fig. 2
Fig. 2
Intersecting effects of synuclein and mitochondria on synaptic transmission and neuronal death? In healthy neurons, synuclein is believed to regulate neurotransmitter release. A fraction of synuclein also interacts with mitochondria, but the consequences of this interaction for mitochondrial function or synaptic transmission are unknown. In Parkinson’s disease, a greater fraction of synuclein interacts with mitochondria, and subsequent impairments in mitochondrial function may adversely affect synaptic transmission and predispose to neuronal death

References

    1. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861–870. doi: 10.1093/brain/awf080. - DOI - PubMed
    1. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, et al. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl. 5):S21–S23. - PubMed
    1. Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Burden of parkinsonism: a population-based study. Mov Disord. 2003;18:313–319. doi: 10.1002/mds.10333. - DOI - PubMed
    1. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045–2047. doi: 10.1126/science.276.5321.2045. - DOI - PubMed
    1. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18:106–108. doi: 10.1038/ng0298-106. - DOI - PubMed

Publication types

Substances